Med-Chemist : "Quintessential Medicinal Chemistry"
Showing posts with label
Recorlev
.
Show all posts
Showing posts with label
Recorlev
.
Show all posts
Thursday, March 10, 2022
FDA Approves Recorlev (levoketoconazole) for the Treatment of Endogenous Hypercortisolemia in Adult Patients With Cushing’s Syndrome
›
Xeris Biopharma Holdings, Inc. (Nasdaq: XERS), announce the U.S. Food and Drug Administration (FDA) approval of Recorlev ® (levoketoconazo...
›
Home
View web version
